Introduction – Addressing Primary Packaging Material Selection for Topical Pharmaceuticals
Global Leading Market Research Publisher QYResearch announces the release of its latest report *“Medicinal Hose – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”*. For pharmaceutical formulators of topical creams, gels, and ointments, the choice of primary packaging — specifically the medicinal hose (collapsible tube) — directly impacts product stability, patient compliance, and regulatory approval. Unlike rigid containers, flexible hoses allow complete product evacuation, reducing waste and improving dosing accuracy. However, manufacturers face a critical decision: selecting between metal hoses (aluminum, superior barrier), plastic hoses (polyethylene/polypropylene, lower cost), and composite hoses (multi-layer laminates, balancing performance and aesthetics). Each material class presents distinct trade-offs in oxygen/moisture transmission, chemical compatibility with active pharmaceutical ingredients (APIs), filling line adaptability, and end-of-life recyclability. This report analyzes how three core primary pharmaceutical packaging keywords—Barrier Performance, Formulation Compatibility, and Dispensing Integrity—are shaping the global medicinal hose market across dermatological, ophthalmic, and wound care applications.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5983208/medicinal-hose
1. Product Definition and Technical Context – The Collapsible Primary Container for Semi-Solids
A medicinal hose (also referred to as a pharmaceutical collapsible tube, squeeze tube, or medicinal collapsible container) is a flexible, deformable primary packaging container designed for unit- or multi-dose dispensing of semi-solid pharmaceutical formulations. Unlike bottles or jars requiring spatulas or finger dipping (hygiene concerns, inaccurate dosing), the collapsible hose permits direct, controlled application to skin or mucous membranes. Key functional requirements include: (a) complete product evacuation (≤5% residual), (b) consistent crimp or seal integrity preventing contamination, (c) compatibility with high-speed filling lines (100–300 tubes/minute), (d) patient-friendly reopening and reclosure (caps or membranes). Based on QYResearch historical analysis (2021–2025) and forecast calculations (2026–2032), the global market is positioned for steady growth, driven by generic topical drug expansion, biosimilar dermatological entries, and regulatory emphasis on container–closure integrity (CCI) testing.
2. Market Drivers – API Protection, Generic Expansion, and Sustainability Pressures
Several convergent forces shape material preferences across the medicinal hose market:
- API Sensitivity Dictates Material Choice: Oxidation-prone APIs (corticosteroids, retinoids, vitamin D analogs) require near-absolute oxygen barrier — only metal hoses (aluminum) achieve oxygen transmission rates (OTR) below 0.01 cm³/m²/day. Moisture-sensitive hydrogels demand low moisture vapor transmission (MVTR) — aluminum again excels, followed by composite laminates with ethylene vinyl alcohol (EVOH) barrier layers. Robust, hydrolysis-resistant APIs (e.g., petrolatum-based ointments) can tolerate plastic hoses (polyethylene/PP), which offer OTR >100 cm³/m²/day.
- Generic Topical Product Launches (2024–2026): Patent expiries for blockbuster dermatological creams (e.g., betamethasone valerate, clobetasol propionate, miconazole nitrate) have triggered an influx of generic entries. Generic manufacturers often replicate the reference listed drug’s (RLD) material choice to smooth regulatory approval, driving demand for all three material categories depending on the brand product’s specification.
- Regulatory Container–Closure Integrity (USP <1207>, <671>): Recent revisions require deterministic CCI testing for semi-solid drug products. Metal hoses (seamless monobloc extrusion) and composite hoses (military-spec side-seal or welded construction) generally outperform blow-fill-seal plastic hoses in passing vacuum decay and high-voltage leak detection protocols.
- Sustainability and Recyclability (EU PPWR 2026, US EPR laws): Plastic hoses (mono-material PE/PP) are mechanically recyclable but require decontamination. Metal hoses are infinitely recyclable in aluminum streams. Composite hoses (mixed materials: PE/aluminum/EVOH/paper labels) are generally non-recyclable in conventional systems, facing increasing regulatory scrutiny.
3. Technical Deep-Dive – Material Performance Comparison and Selection Criteria
The medicinal hose market segments by material type, each with distinct technical characteristics, cost structures, and application suitability:
Metal Hose (Aluminum – Extruded Monobloc):
- Construction: Seamless impact extrusion from aluminum slugs (0.08–0.15 mm wall thickness). No side seam — eliminates potential leakage path.
- Barrier Performance: OTR <0.01, MVTR <0.001 (excellent). Near-complete light protection.
- Chemical Compatibility: Requires internal protective lacquer (epoxy-phenolic, polyamide-imide, or PE film) to prevent aluminum–formulation contact. Not suitable for high-chloride formulations (e.g., benzalkonium chloride-preserved gels) without specialized liner.
- Cost: Highest among three types (US$0.15–0.40 per tube in high volume).
- Sustainability: Fully recyclable.
- Preferred Applications: Oxidation-sensitive creams (hydrocortisone, tacrolimus), ophthalmic ointments (sterile), moisture-sensitive hydrogels, premium dermatological brands.
Plastic Hose (Polyethylene/Polypropylene – Extruded or Co-extruded Blow-Fill-Seal):
- Construction: Mono-layer (LDPE) or multi-layer (PE/adhesive/EVOH/PE) extruded tube with welded or molded shoulder/nozzle.
- Barrier Performance: Poor for mono-layer (OTR >100, MVTR >1.0); moderate for multi-layer with EVOH (OTR 0.5–3.0, MVTR 0.05–0.2).
- Chemical Compatibility: Broadly compatible with aqueous and oil-based formulations. No internal lacquer required; no metal-ion leaching risk.
- Cost: Lowest among three types (US$0.06–0.15 per tube).
- Sustainability: Mono-material PE/PP recyclable where collection exists; multi-layer EVOH laminates non-recyclable.
- Preferred Applications: Non-oxidizing over-the-counter (OTC) creams, moisturizers, low-cost generic ointments, sample/trial sizes.
Composite Hose (Multi-Layer Laminate – Side-Sear or Welded):
- Construction: Multiple co-extruded layers (e.g., PE/paper/PE/Al/PE or PE/EVOH/PE) formed into a tube with a welded side seam or polymeric adhesive seal.
- Barrier Performance: Highly tunable — with aluminum foil layer, OTR <0.1, MVTR <0.01; with EVOH only, moderate barrier.
- Chemical Compatibility: Broad compatibility due to inert PE inner layer. No metal contact with formulation.
- Cost: Intermediate between plastic and metal (US$0.09–0.22 per tube).
- Sustainability: Mixed materials make recycling difficult; specialized de-lamination processes required.
- Preferred Applications: Aesthetic/photographic-quality printing (cosmeceuticals), tubes needing very high oxygen barrier but metal-free formulation contact, export products where recycling compliance is less regulated.
4. Segment Analysis – Material Type and Application Differentiation
By Material Type:
- Metal Hose (Largest revenue share, ~45–50%): Premium segment, concentrated among specialized European manufacturers (Alltub, Montebello, LINHARDT, Almin). Slower growth (CAGR 2–3%) due to cost pressure from composites, but defensible in regulated prescription dermatology and ophthalmic categories.
- Plastic Hose (Largest unit volume, ~40–45% of tubes): Fastest-growing segment in emerging markets (Asia-Pacific, Latin America) where cost constraints dominate. Dominated by Asian high-volume suppliers and global packaging converters. High competition, low margins.
- Composite Hose (Fastest-growing value segment, CAGR 5–6%): Gains share from metal in cosmeceutical and OTC categories where brands require premium printing aesthetics (photorealistic graphics, matte/gloss finishes) but seek lower cost than aluminum or metal-package risk profile. European and North American converters lead innovation.
By Formulation Type (Application):
- Creams (Largest share, ~40% of volume): Emulsions (oil-in-water, water-in-oil). Metal and composite hoses preferred for barrier-sensitive creams with natural oils (rancidity risk). Plastic hoses used for low-cost, short-shelf-life (12 months) formulations.
- Gels (Fastest-growing segment): Hydrogels (water-based) or organogels (solvent-based). Gels with volatile solvents demand low MVTR — metal hoses dominate prescription gel segment; composite with EVOH serves OTC gel market.
- Ointments (Stable, ~25% of volume): Anhydrous (petrolatum, wax-based). Less sensitive to moisture but oxidation-prone if containing unsaturated hydrocarbons. Metal and composite with foil layer preferred; plastic only for very short-duration products.
- Other (Veterinary, dental, hospital bulk): Smaller volume, typically metal (veterinary pastes requiring long shelf life) or plastic (single-use dental anesthetic gels).
5. Exclusive Industry Observation – The Generic Manufacturer’s Material Migration Risk
Based on QYResearch primary interviews with contract manufacturing organizations (CMOs) and generic drug formulation scientists (August–November 2025), a concerning trend has emerged: generic manufacturers increasingly attempt to substitute lower-cost plastic or composite hoses for metal hoses specified in the reference listed drug (RLD). While immediate cost savings are significant (40–60% reduction in packaging spend), accelerated stability studies (ICH 40°C/75% RH, 6 months) reveal frequent failures:
- Weight loss exceeding 5% (moisture ingress in plastic/composite without foil) for hydrogels and emulsion creams
- API degradation >10% (oxidation) for corticosteroids and retinoids stored in mono-layer plastic
- Change in pH >0.5 units (carbon dioxide ingress through plastic) affecting preservative efficacy
The financial impact of a failed stability study (reformulation, revalidation, delayed launch) typically exceeds the packaging cost savings by a factor of 5–10×. Consequently, seasoned generic houses now maintain RLD-specified material type unless extensive formulation protection is proven. This behavior reinforces incumbent position of metal hoses for prescription dermatology products where API sensitivity is high.
6. Competitive Landscape – European Specialists, Asian Volume Suppliers, and Composite Innovators
The medicinal hose market exhibits distinct regional and material specialization:
- Metal Hose Specialists (Europe-dominated): Alltub (France/Germany, global leader in pharmaceutical aluminum monobloc tubes, proprietary internal lacquer formulations for aggressive APIs), Montebello Packagings (Italy, sterile ophthalmic and injectable-grade hose expertise), LINHARDT (Germany, high-precision extrusion with in-line printing), Almin Extrusion (UK), Ambertube (France), Tecnotubetti (Italy), La Metallurgica (Italy), Alucon (Germany). These suppliers command premium prices (generally US$0.20–0.50+) but provide validated CCI data, Drug Master Files, and regulatory submission support.
- Plastic Hose Volume Suppliers (Asia-Pacific dominant): Hubei XIN JI Pharmaceutical Packaging Co., Ltd., Shunfeng Pharmaceutical Packaging Materials Co., Ltd., Shanghai Jiatian Pharmaceutical Packaging Co., Ltd., SanYing Packaging (China), Viva Healthcare Packaging (India). Produce standard multi-layer and mono-layer PE/PP hoses at US$0.06–0.15 per tube. Growing quality certifications (ISO 15378:2017 primary pharmaceutical packaging) enable exports to Africa, Southeast Asia, and Latin American markets.
- Composite Hose Innovators (Global): Xinrontube Packaging (China, cross-licensed technology from European partners), Pioneer Group (India), Simal Packaging (India). These suppliers focus on cosmeceutical and OTC segments requiring high-barrier composites with advanced print capabilities (rotogravure, screen printing, cold foil stamping).
- Additional Regional Players: Viva Healthcare Packaging (India – plastic hose specialist), complete coverage of Asian and Middle Eastern generic markets.
7. Application Spotlight – Sterile Ophthalmic Ointment Hoses: The Most Demanding Use Case
Ophthalmic ointments (e.g., erythromycin, tetracycline, tobramycin) for treating bacterial conjunctivitis represent the most stringent medicinal hose application. Requirements include:
- Sterile-filled metal hoses only — plastic and composite hoses have not reliably passed sterility validation (due to side seams or extractables)
- Seamless monobloc aluminum construction eliminates microbial ingress path
- Gamma or ETO sterilization of empty hoses (supplied in sealed pouches) prior to aseptic filling
- Extended nozzle designs (8–12 mm) enabling direct conjunctival application without touching the eye
- Child-resistant caps (CRC) meeting ASTM D3475 for certain antibiotics (toxicity risk in pediatric ingestion)
This subsegment accounts for only 5–8% of unit volume but commands 3–5× pricing (US$0.50–0.80 per hose) and is supplied exclusively by Alltub, Montebello, and Almin Extrusion.
8. Future Outlook – Digital Printing, Serialization, and Material Simplification
Three emerging trends will shape the medicinal hose market through 2032:
- Direct Digital Printing (Inkjet onto Hoses): Eliminates label application, reduces changeover time, and supports variable data — lot numbers, expiry dates, and serialized 2D barcodes (GS1 DataMatrix) for EU Falsified Medicines Directive (FMD) and US Drug Supply Chain Security Act (DSCSA) compliance. Alltub and Ambertube have deployed commercial digital lines at 200–300 hoses/minute.
- Mono-Material Plastic Hoses (Recyclability by Design): In response to EU PPWR, plastic hose manufacturers are developing mono-material PE hoses with no EVOH or adhesive layers, using alternative barrier technologies (SiO₂ or AlOx coatings on PE). While coating barriers are lower than foil laminates, they may suffice for short-shelf-life APIs, enabling recyclable plastic hose solutions.
- Regulatory Push for Metal Where Biocompatibility Data Exists: The growing drug master file (DMF) database for generic topical APIs includes specific reference to aluminum hose suppliers. Switching material class triggers substantial regulatory filing updates (Type II variation in EU, Prior Approval Supplement in US), motivating manufacturers to remain with specified metal or composite.
9. Conclusion – Strategic Implications for Drug Manufacturers and Packaging Suppliers
The medicinal hose is not a one-size-fits-all primary packaging component. The choice between metal, plastic, and composite hoses must be driven by API sensitivity (oxidation/moisture/hydrolysis risk), regulatory pathway (RLD comparison, required CCI validation data), and sustainability targets. For high-value prescription dermatological and ophthalmic products, metal hoses remain the gold standard despite higher cost. For OTC and cosmeceutical creams where printing aesthetics matter and barrier demands are moderate, composite hoses offer the best balance. For emerging market generics with short shelf-life requirements and extreme cost sensitivity, plastic hoses are defensible when API robustness is proven. As digital printing and serialization mandates converge, suppliers offering integrated printed hoses with validated barrier performance will capture premium share across all three material categories.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
